↓ Skip to main content

Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial

Overview of attention for article published in Oncologist, June 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
2 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial
Published in
Oncologist, June 2021
DOI 10.1002/onco.13830
Pubmed ID
Authors

Sara A. Hurvitz, Cristina Saura, Mafalda Oliveira, Maureen E. Trudeau, Beverly Moy, Suzette Delaloge, William Gradishar, Sung-Bae Kim, Barbara Haley, Larisa Ryvo, Ming-Shen Dai, Vladimir Milovanov, Jesús Alarcón, Sujith Kalmadi, Eduardo Cronemberger, Cristiano Souza, Luciana Landeiro, Ron Bose, Judith Bebchuk, Fairooz Kabbinavar, Richard Bryce, Kiana Keyvanjah, Adam M. Brufsky

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 24%
Other 2 12%
Student > Ph. D. Student 2 12%
Researcher 2 12%
Student > Postgraduate 1 6%
Other 0 0%
Unknown 6 35%
Readers by discipline Count As %
Medicine and Dentistry 8 47%
Nursing and Health Professions 2 12%
Unknown 7 41%

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 December 2021.
All research outputs
#2,182,088
of 19,907,236 outputs
Outputs from Oncologist
#480
of 3,369 outputs
Outputs of similar age
#53,315
of 345,691 outputs
Outputs of similar age from Oncologist
#21
of 113 outputs
Altmetric has tracked 19,907,236 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,369 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.0. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 345,691 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 113 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.